Daytime symptoms of chronic obstructive pulmonary disease: a systematic review

Abstract

There is no single source of compiled data on symptoms experienced by patients with chronic obstructive pulmonary disease (COPD) when awake and active throughout the day. The aim of this systematic review was to evaluate the prevalence, variability, and burden (i.e., bothersomeness and/or intensity), and the impact of daytime COPD symptoms on other outcomes. The review also evaluated the impact of interventions and the measures/tools used to assess daytime COPD symptoms in patients. A systematic literature search was conducted using the primary search terms "COPD", "symptoms", and "daytime" in EMBASE®, MEDLINE®, MEDLINE® In-Process, and CENTRAL in 2016, followed by an additional search in 2018 to capture any new literature that was published since the last search. Fifty-six articles were included in the review. The accumulated evidence indicated that the symptomatic burden of COPD appears greatest in the morning, particularly upon waking, and that these morning symptoms have a substantial impact on patients' ability to function normally through the day; they also worsen quality of life. A wide variety of tools were used to evaluate symptoms across the studies. The literature also confirmed the importance of pharmacotherapy in the management of daytime COPD symptoms, and in helping normalize daily functioning. More research is needed to better understand how COPD symptoms impact daily functioning and to evaluate COPD symptoms at well-defined periods throughout the day, using validated and uniform measures/tools. This will help clinicians to better define patients' needs and take appropriate action.npj Primary Care Respiratory Medicine (2020) 30:6 ; https://doi.

How to Assess Breathlessness in Chronic Obstructive Pulmonary Disease

“…There have been extensive developments in the field of breathlessness assessment over the last 30 years, with a multitude of assessment instruments now available to capture information on the breathlessness experience of people with COPD in different settings and contexts. A number of previous reviews have provided a summary of available breathlessness assessment approaches in these varied contexts, including instruments to assess breathlessness at specific times of the day (ie, morning symptoms), 126 to capture the multiple dimensions of breathlessness 127 and specific to people with advanced disease. 49 The current review focuses on the assessment of activity-related breathlessness experienced in daily life or in response to an exercise provocation.…”

Relationship between Peak Inspiratory Flow and Patient and Disease Characteristics in Individuals with COPD—A Systematic Scoping Review

“…Studies were included in the data analysis if they met the following criteria: (1) published in English; (2) included mention of PIF in the title or abstract; (3) mentioned factors associated with PIF (either patient-or disease-related); and (4) published after 1 January 2000. Published articles were excluded if they: (1) were congress articles or abstracts, reviews, letters to the editor or responses; or (2) did not mention factors associated with PIF. Articles were excluded if standalone data were not available on patients with COPD.…”

Coronavirus Disease (COVID-19): Challenges and Opportunities

“…Its symptoms include fever, cough, anddifficulty in breathing [7][8][9][10]. Anxiety is also considered as a psychological symptom and a common symptom in patients with chronic respiratory disorders and can significantly reduce patients' quality of life [11][12][13].…”